Techcyte SureView cervical cytology system validation study
Part of Women’s health & pregnancy clinical trials.
This study is testing a new computer system (Techcyte SureView) that helps doctors read Pap test slides. If you have a glass slide from a previous Pap test that meets the requirements, your slide could be used to help validate this system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a glass slide from a Pap test that was prepared with either Hologic ThinPrep or BD SurePath method.
- Your slide should have the original diagnosis available.
- Your slide must be 5 years old or less (except for rare specimens).
- Your slide must not be broken, cracked, or have air bubbles or scratches.
- Your slide must not have permanent markings that can't be removed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
This trial is testing a new screening tool (ELEVATE) to see how well it works in detecting cervical precancer. If you have an abnormal pap smear or a positive HPV test and are scheduled for a colposcopy, you may be able to help validate this tool.
This study tests a new type of microscope that can take high-quality pictures of cervical tissue samples right in the clinic during a biopsy or LEEP procedure. It may help doctors see the tissue more clearly and quickly, without needing to send it to a lab.
This study checks whether a smartphone-based AI tool can help screen for cervical cancer. You may be offered the AI-assisted screening during a clinic visit to see if it works well when visualizing the cervix.
This study is testing a new, non-invasive way to screen for cervical cancer. It uses a photoelectric device and an epigenetic test done on a sample from your cervix. The goal is to find early signs of cancer more accurately than current methods.
Hear when a new Cervical Cytology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.